4//SEC Filing
SAHA SAURABH 4
Accession 0001847903-25-000055
CIK 0001847903other
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 5:43 PM ET
Size
8.5 KB
Accession
0001847903-25-000055
Insider Transaction Report
Form 4
SAHA SAURABH
DirectorChief Executive Officer
Transactions
- Sale
Ordinary Shares
2025-04-22$12.43/sh−40,344$501,476→ 221,017 total - Sale
Ordinary Shares
2025-04-21$12.29/sh−14,656$180,100→ 261,361 total
Holdings
- 38,000(indirect: By Trust)
Ordinary Shares
Footnotes (5)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.23 to $12.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.23 to $12.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]These shares are held directly in a trust, for which the Reporting Person and his spouse serve as trustees.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001861926
Filing Metadata
- Form type
- 4
- Filed
- Apr 21, 8:00 PM ET
- Accepted
- Apr 22, 5:43 PM ET
- Size
- 8.5 KB